Navigation Links Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing

Current Revatrol formulation has 100MG of actual resveratrol plus 95% OPCs

and three key antioxidants

BOCA RATON, Fla., Nov. 19 /PRNewswire/ -- Revatrol's manufacturer, Renaissance Health Publishing, LLC, is disappointed and confused as to why's recent study on red wine supplements analyzes an out-of-date formulation of Revatrol, and calls on the for-profit laboratory to remove the current information it portrays for Revatrol from its study and to retest Revatrol's current product, which has been on the market for more than nine (9) months.

"I vehemently object to the comparative study of Revatrol, as its analysis is based on an out-of-date formulation that has been off the market for more than 9 months," says James DiGeorgia, CEO of Renaissance Health Publishing, LLC. "While that out-of-date formulation was superb, and accurately represented in our advertising, Renaissance Health Publishing, LLC has demanded that remove Revatrol from its November 13, 2007 comparative study because it does not in any way accurately represent the current formulation of Revatrol.

"We recognize the fact that has added a note to the study that points out that the Revatrol formulation tested is discontinued, but that's insufficient. The study is still misleading and deceptive because they used a formulation of Revatrol that's nine months old and not the current formulation."

The truth about Revatrol, which would have determined had it exercised adequate due-diligence and tested the current formulation, is that Revatrol contains:

-- 100MG of Actual Resveratrol

-- 100MG Alpha Lipoic Acid

-- 100MG Acetyl-L-Carnitine

-- 100MG Quercetin

In addition, based on the standards and measures used by, Revatrol currently delivers 100MG of actual resveratrol for as little as 30 cents, plus contains a 95% OPC feature and an additional 100MG of each of three key antioxidants.

"We're unaware of any formulation of the market that can compare to Revatrol. I and my entire firm are very proud of Revatrol," says DiGeorgia. "We've been unfairly attacked by competitors ever since we launched Revatrol. All I can assume is they just can't measure up when consumers really compare Revatrol to the competition."

Renaissance Health Publishing, LLC implores to re-examine its product procurement and testing policies, so when it makes representations about the products it tests, the representations apply to current formulations.

Renaissance Health Publishing, LLC asked on November 13, 2007, to show its independence by recognizing its error in testing the retired formulation and retest Revatrol at its own expense. As of this release date, -- which claims to be an "independent lab" -- has requested a $3,000 to $4,000 fee from Renaissance Health Publishing, LLC to evaluate the current formulation of Revatrol.

DiGeorgia asserts, "I'm simply astounded by what appears to me to be a total lack of intellectual honesty at work in this situation. If is truly independent and unbiased why wouldn't they immediately recognize the error in testing, and prominently disclose that they tested an old out-of-date formulation they purchased more than nine (9) months ago for their comparative study, and immediately take steps to test the current formula?

"We'd be thrilled with this study had it really examined the Revatrol formulation on the market all these months. We have no doubt a fair scientific analysis would have proved how wonderful Revatrol really is. For that to happen will still have to test the right product, the current Revatrol formulation, at its own expense."

"Our own in house laboratory tests that we have 113% of the ingredients we claim in our Revatrol formulation. We've decided to use another outside lab to test our product. As it turns out the $3,000 to $4,000 fee requested by for testing can be done for as little as $800," insists DiGeorgia. "We don't get a fancy seal from that we can put on our website and product boxes, but we do get an accurate analysis of our products' current formulation."

For more information on Revatrol and its potent anti-aging benefits, please visit or call our knowledgeable representatives at 1-866-482-6678.

SOURCE Renaissance Health Publishing, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... December 1, 2015 --> ... research report "Nucleic Acid Labeling Market by Product (Reagents ... Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), ... MarketsandMarkets, The global market is expected to reach USD ... 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
Breaking Medicine Technology: